NeuroSense Therapeutics prices $4.5M stock and warrants offering
- NeuroSense Therapeutics (NASDAQ:NRSN) priced a public offering of common shares and a concurrent private placement of warrants to raise $4.5 million, the company said Thursday.
- The company priced 3 million ordinary shares at $1.50 apiece.
- The company also priced the concurrent private placement of ordinary warrants to purchase up to 3 million ordinary shares with an exercise price of $1.50 per ordinary share.
A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.
Recommended For You
Comments
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.